A further £5 million is to be injected into Manchester to help transform personalised medicine for cancer treatment.
The news follows last week’s launch of the new cancer research building in Manchester.The Cancer Research UK Manchester Centre is one of the first of CRUK’s Centres to gain Major Centre status, and in doing so will receive an extra £5 million over two years.
The Centre will act as a vital research hub for the Cancer Research UK centre network, drawing together expertise, encouraging collaborative research, and bridging the gap between innovative laboratory work and benefits for patients.
The Centre benefits from a strong partnership with The University of Manchester and The Christie NHS Foundation Trust. It is a leading cancer research institute within The University of Manchester, core funded by Cancer Research UK.
By becoming a Major Centre, the Cancer Research UK Manchester Centre will focus on four main themes; discovery of new biomarkers, clinical trials, analysing cells and tissues, and innovations in radiotherapy and imaging. Turning this into reality means more investment in infrastructure and technology, allowing patients to benefit from basic and clinical research.
The team will lead the way in personalised medicine by analysing the genetic makeup of patients’ individual cancers. Researchers will profile blood samples at diagnosis and throughout the patient’s journey looking for DNA and cancer cells that are released from the tumour.
The information will then be used to help doctors pick the best treatments, including radiotherapy, chemotherapy and new drugs, and to adapt treatment as the patient’s tumour progresses and evolves.
Professor Nic Jones, chief scientist at Cancer Research UK and director of the Cancer Research UK Manchester Centre, said: “There has been great progress in cancer survival rates over the last 40 years with survival doubling, but many challenges remain. The Centre will invest not only in collaborative and innovative research, but in the next generation of world-leaders in cancer detection, treatment and prevention.”